Health Care Equipment & Services

Stone Warren’s latest buy of NeoGenomics shares signals strong confidence in its ALS therapy pipeline and long‑term growth prospects.

Dexcom insiders’ steady, near‑market sales show routine portfolio rebalancing, not a warning—stock remains driven by strong fundamentals and growth.

Insider buying surge at Sensus Healthcare shows board confidence, hinting at a bullish outlook amid undervaluation.

Marion’s 57,600‑RSU grant at OptimizeRx signals long‑term confidence, revealing insider buying trends and potential future stock impact.

Insider selling spree at Aveanna Healthcare: J.H. Whitney liquidates 10M+ shares at $11.50, below market. Explore the impact on dilution, control shifts, and investor strategy.

Hinge Health CFO’s recent insider sale shows routine portfolio rebalancing, not a red flag—stock climbs 17% monthly, offering a discount opportunity.

CEO Jeff sells 90k shares of Aveanna before a $15 M secondary offering, sparking insider confidence yet hinting at future dilution risks.

Kevin R. Sayer’s latest 10b‑5‑1 sale at Dexcom shows routine portfolio management—over 900k shares sold yet the company’s solid growth, cash, and product pipeline stay intact for investors.

Intuitive Surgical insider selling shows steady, pre‑planned moves amid a high valuation—no sudden red flags, but a cautious long‑term outlook.

Rong Rudy’s August sell‑off of 1,000 ZeroStack shares at $7.57 signals caution amid volatile swings, prompting investors to watch for further insider moves.